Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neuropathology (Kyoto. 1993)

• Publication date

  2014-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/neup.12143PMID 25124031
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia

  2014cited by this paper
• Criteria for the diagnosis of corticobasal degeneration

  2013cited by this paper
• An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement

  2013cited by this paper
• Globular glial tauopathies (GGT): consensus recommendations

  2013cited by this paper
• Atomic identification of fluorescent Q-dots on tau-positive fibrils in 3D-reconstructed pick bodies.

  2012cited by this paper
• Perivascular orientation of astrocytic plaques and tuft-shaped astrocytes.

  2011cited by this paper
• Does corticobasal degeneration exist? A clinicopathological re-evaluation.

  2010cited by this paper
• Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study

  2009cited by this paper
• Cognitive and motor assessment in autopsy-proven corticobasal degeneration

  2007cited by this paper
• Widespread spinal cord involvement in progressive supranuclear palsy

  2007cited by this paper
• Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.

  2007cited by this paper
• Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy

  2007cited by this paper
• Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies

  2006influential reference
• Ultrastructural characteristics of tau filaments in tauopathies: Immuno‐electron microscopic demonstration of tau filaments in tauopathies

  2006cited by this paper
• Correlated light and electron microscopic imaging of multiple endogenous proteins using Quantum dots

  2005cited by this paper
• Commentary on: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism, by

  2005cited by this paper
• Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration?

  2005cited by this paper
• Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.

  2005cited by this paper
• Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

  2005cited by this paper
• Discrepancy between clinical and pathological diagnoses of CBD and PSP

  2005cited by this paper
• Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia

  2005cited by this paper
• Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration.

  2004cited by this paper
• Identification of amino‐terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration

  2004cited by this paper
• Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer's disease or progressive supranuclear palsy

  2004cited by this paper
• Further observations on Tau-positive glia in the brains with progressive supranuclear palsy

  2004cited by this paper
• Distribution of tuft-shaped astrocytes in the cerebral cortex in progressive supranuclear palsy

  2004influential reference
• Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain

  2004cited by this paper
• Progressive supranuclear palsy presenting with primary progressive aphasia—Clinicopathological report of an autopsy case

  2003cited by this paper
• 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy

  2003cited by this paper
• Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain

  2003cited by this paper
• Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process

  2002cited by this paper
• Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration

  2002cited by this paper
• [Corticobasal degeneration].

  2001cited by this paper
• [An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy].

  2000cited by this paper
• Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy

  1999cited by this paper
• Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy

  1999cited by this paper
• Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia

  1999cited by this paper
• Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy

  1998influential reference
• Basic pathology of corticobasal degeneration

  1997cited by this paper
• Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders

  1996cited by this paper
• Synthesis and Characterization of Strongly Luminescing ZnS-Capped CdSe Nanocrystals

  1996cited by this paper
• A variety of glial pathological structures by the modified Gallyas‐Braak method

  1996cited by this paper
• Widespread cytoskeletal pathology characterizes corticobasal degeneration.

  1995cited by this paper
• Immunohistochemical investigation of tau-positive structures in the cerebral cortex of patients with progressive supranuclear palsy.

  1995cited by this paper
• Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)

  1994cited by this paper
• Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue.

  1992cited by this paper
• Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy.

  1992cited by this paper
• [Widespread tau abnormality in a case of cortico-basal degeneration].

  1992cited by this paper
• Cortical‐basal ganglionic degeneration

  1990cited by this paper
• Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging.

  1990influential reference
• Clinical and pathological features of corticobasal degeneration.

  1990cited by this paper
• Corticobasal degeneration.

  1989cited by this paper
• Spinal cord lesions in progressive supranuclear palsy: some new observations

  1986cited by this paper
• A Guide to Neuropathology

  1982cited by this paper
• Progressive supranuclear palsy.

  1972cited by this paper
• Corticodentatonigral degeneration with neuronal achromasia.

  1968cited by this paper
• Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life.

  1967cited by this paper

• Progressive Supranuclear Palsy-A Global Review.

  2025cites this paper
• Differences in the soluble and insoluble proteome between primary tauopathies

  2025cites this paper
• Multifactorial etiology of progressive supranuclear palsy (PSP): the genetic component

  2025cites this paper
• Neuropathological Research Developed From the Analysis of Forensic Autopsy Cases

  2025cites this paper
• The Genetic Background of the Immunological and Inflammatory Aspects of Progressive Supranuclear Palsy

  2025cites this paper
• Selective cellular and regional vulnerability in frontotemporal lobar degeneration: a scoping review

  2025cites this paper
• Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease.

  2025cites this paper
• Inflammatory and Neurotrophic Factors and Their Connection to Quality of Life in Progressive Supranuclear Palsy—Single-Center Study

  2025cites this paper
• Increase in wasteosomes (corpora amylacea) in frontotemporal lobar degeneration with specific detection of tau, TDP-43 and FUS pathology

  2024cites this paper
• Age-Related Pathology in Corticobasal Degeneration

  2024cites this paper
• The enigma of depression in corticobasal degeneration, a frequent but poorly understood co-morbidity

  2024cites this paper
• Iron(ing) out parkinsonisms: The interplay of proteinopathy and ferroptosis in Parkinson's disease and tau-related parkinsonisms

  2024cites this paper
• Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases

  2024cites this paper
• Subcortical tau burden correlates with regional brain atrophy and plasma markers in four-repeat tauopathy parkinsonism

  2024cites this paper
• Tau processing and tau-mediated inflammation differ in human APOEε2 and APOEε4 astrocytes

  2024cites this paper
• Toward an animal model of Progressive Supranuclear Palsy

  2024cites this paper
• Legumain/asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment.

  2024cites this paper
• An autopsy case of progressive supranuclear palsy with severe corticospinal tract degeneration

  2024cites this paper
• Persistence of Kii amyotrophic lateral sclerosis after the 2000s and its characteristic aging-related tau astrogliopathy.

  2024cites this paper
• Neuropathological substrate of incident dementia in older patients with schizophrenia: A clinicopathological study

  2023cites this paper
• Detailed Assessment of 18F-THK5351 Distribution Pattern in the Midbrain: Comparison With Progressive Supranuclear Palsy and Corticobasal Syndrome

  2023cites this paper
• Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration

  2023cites this paper
• How should we be using biomarkers in trials of disease modification in Parkinson’s disease?

  2023cites this paper
• Clinical application of MAO‐B PET using 18F‐THK5351 in neurological disorders

  2023cites this paper
• Astrocytes in human central nervous system diseases: a frontier for new therapies

  2023cites this paper
• Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy.

  2023cites this paper
• Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathology

  2022cites this paper
• Do Sleep Disturbances have a Dual Effect on Alzheimer’s Disease?

  2022cites this paper
• Progressive supranuclear palsy with predominant frontal presentation exhibiting progressive nonfluent aphasia due to crossed aphasia

  2022cites this paper
• SUMO1 Modification of Tau in Progressive Supranuclear Palsy

  2022cites this paper
• Neuropathological changes in advanced Parkinson’s disease

  2022cites this paper
• Macroscopic diagnostic clue for parkinsonism

  2022influential citation
• Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration

  2022cites this paper
• Simple and clear differentiation of spinocerebellar degenerations: Overview of macroscopic and low‐power view findings

  2022cites this paper
• Clinical Spectrum of Tauopathies

  2022cites this paper
• Neuropathology and emerging biomarkers in corticobasal syndrome

  2022cites this paper
• A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome

  2022cites this paper
• The hot cross bun sign in corticobasal degeneration

  2021cites this paper
• Mass spectrometry analysis of tau and amyloid‐beta in iPSC‐derived models of Alzheimer’s disease and dementia

  2021cites this paper
• Deep Learning-Based Image Classification in Differentiating Tufted Astrocytes, Astrocytic Plaques, and Neuritic Plaques.

  2021cites this paper
• Genetic pleiotropy and the shared pathological features of corticobasal degeneration and progressive supranuclear palsy: a case report and a review of the literature

  2021influential citation
• Machine learning‐based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration

  2021influential citation
• Immunohistochemical Study of Mitochondrial Ferritin in the Midbrain of Patients with Progressive Supranuclear Palsy

  2021cites this paper
• Degenerative Diseases of the CNS

  2021cites this paper
• The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

  2021cites this paper
• 18F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies

  2021cites this paper
• Pathology of different tau protein species in neurodegenerative diseases: Alzheimer’s disease, corticobasal degeneration, and progressive supranuclear palsy

  2021cites this paper
• Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP)

  2020cites this paper
• Progressive supranuclear palsy: Advances in diagnosis and management.

  2020cites this paper
• Astroglia and Tau: New Perspectives

  2020cites this paper
• Molecular profiling in Parkinsonian syndromes: CSF biomarkers.

  2020cites this paper
• Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome: A 11C-Pyridinyl-Butadienyl-Benzothiazole 3 PET Pilot Study.

  2020cites this paper
• Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration

  2020influential citation
• Cellular Biology of Tau Diversity and Pathogenic Conformers

  2020cites this paper
• Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration

  2020influential citation
• Small molecule modulation of the p75 neurotrophin receptor suppresses age- and genotype-associated neurodegeneration in HIV gp120 transgenic mice.

  2020cites this paper
• Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders

  2019cites this paper
• Astroglial contribution to tau-dependent neurodegeneration.

  2019cites this paper
• Tau exhibits unique seeding properties in globular glial tauopathy

  2019cites this paper
• Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy

  2019cites this paper
• Neuroinflammation as a Common Feature of Neurodegenerative Disorders

  2019influential citation
• Four-repeat tauopathies.

  2019cites this paper
• Intercellular Spread of Protein Aggregates in Neurodegenerative Disease.

  2018cites this paper
• Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromes.

  2018cites this paper
• Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype

  2018cites this paper
• Astrogliopathy in Tauopathies

  2018cites this paper
• Protein astrogliopathies in human neurodegenerative diseases and aging

  2017cites this paper
• Cognitive dysfunction in corticobasal degeneration

  2017cites this paper
• Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series

  2017cites this paper
• Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain

  2017cites this paper
• An autopsied case of corticobasal degeneration presenting with frontotemporal dementia followed by myoclonus

  2017cites this paper
• Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases

  2017cites this paper
• Alzheimer ’ s Disease & Dementia Cerebrovascular Lesions in Pick Complex Diseases – A Neuropathological Study with a 7 . 0-Tesla Magnetic Resonance Imaging Study

  2017cites this paper
• Advances in the development of tau PET radiotracers and their clinical applications.

  2016cites this paper
• Tau prion strains in cells, mice, and patients

  2016influential citation
• Movement Disorders: Focus on Parkinson’s Disease and Related Disorders

  2016cites this paper
• Neurodegenerative disorders share common features of "loss of function" states of a proposed mechanism of nervous system functions.

  2016cites this paper
• Pathological and Clinical Spectrum of Progressive Supranuclear Palsy: With Special Reference to Astrocytic Tau Pathology

  2016influential citation
• Physiological functions and pathobiology of TDP‐43 and FUS/TLS proteins

  2016cites this paper
• Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.

  2016influential citation
• Tau physiology and pathomechanisms in frontotemporal lobar degeneration

  2016cites this paper
• Tau and tauopathies.

  2016cites this paper
• Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.

  2016cites this paper
• Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations.

  2016cites this paper
• Longitudinal Clinical Changes of Non-Fluent/Agrammatic Primary Progressive Aphasia as Tau Spectrum Disorder: A Case Report

  2015cites this paper